Investors are beginning to realize that RNAi works and ultimately has the power to switch off any gene, bacterial genes, viruses cancer genes, etc. Its wide open. Alnylan is way past the proof of concept point.
Sentiment: Strong Buy
some day when their drug delivery problems get solves
untill than its a #$%$ shoot and very expensive ar $20